Building A Smarter Potency Strategy For Bispecific Antibodies

When a biotechnology company needed to define a regulatory-ready potency strategy for a bispecific antibody, Solvias developed an approach that combined orthogonal analytical methods with targeted functional assays.

The result was a scientifically justified, phase-appropriate testing strategy that provided mechanistic insight, reduced long-term analytical complexity, and supported regulatory confidence.